BioMed Realty Trust Inc., a San Diego-based real estate investment trust that specializes in properties in the life sciences industry, announced a pricing of a follow-on public offering of 13.1 million shares of common stock at $22.50 per share. The offering was increased from the originally planned 11 million shares.
All the shares are being sold by the company, although underwriters, led by Raymond James & Associates, Inc., were given a 30-day option to purchase some 2 million additional shares.
BioMed Realty Trust, with headquarters in Rancho Bernardo, reported net income of $5.8 million on $24.5 million in revenues for its first quarter ended March 31. Shares of the company, under the ticker BMR, were traded at $23.63 as of June 22.